Press Releases

06:17am Merck : Q1 26 Financial Statement PU
06:17am Merck : Q1 26 Press Release PU
06:17am Merck : Q1 26 Summary PU
06:17am Merck : Darmstadt, Germany, Delivers Solid Start to the Year and Upgrades Full-Year Guidance PU
06:14am Merck : Strategic Update May 13, 2026 PU
05-05 Merck : Darmstadt, Germany, Opens €20 million Metrology and Inspection Site in France for Global Chip Industry PU
04-30 Merck : Darmstadt, Germany, Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations PU
04-24 Merck : (AGM 2026 Presence and Voting Results NA) PU
04-24 Merck : (AGM 2026 Dividend Announcement NA) PU
04-24 Merck : (AGM 2026 GOR Dividend EN NA) PU
04-24 AGM: Beckmann to be appointed as CEO May 1 PU
03-25 Merck KGaA: Freifrau Helene Röder von Diersburg, buy EQ
03-25 Merck KGaA: Belén Garijo Lopez, buy EQ
03-14 Merck : Prospectus - C-032386 PU
03-12 Merck : (AGM 2026 Explanation Shareholder Rights EN NA) PU
03-05 Merck : ESG Presentation PU
03-05 Merck : Q4 25 Earnings Presentation PU
03-05 Merck : Q4 25 Financial Statement PU
03-05 Merck : Q4 25 Summary PU
03-05 Merck KGaA, Darmstadt, Germany: Guidance for 2025 Delivered, Growth Foundation in Place PU
01-29 Merck : Benjamin Hein Appointed as Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO of Electronics PU
01-26 Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements EQ
01-12 Merck : FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor PU
12-22 Merck : Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor PU
12-16 Merck : Darmstadt, Germany, Launches ChemiSphere® App to Simplify Digital Data Access and Boost Lab Efficiency PU
No results for this search